GLP-1 is released from the distal bowel within minutes of a meal and does enhance glucose-dependent insulin production and secretion, decrease glucagon secretion, increase glucose uptake and glycogen synthesis in peripheral tissues, delay gastric emptying, and increase satiety [5], making it an ideal target for diabetes therapy. This evidence concerns the gene GCG and diabetes mellitus.